PT2726510T - Direcionamento duplo - Google Patents

Direcionamento duplo

Info

Publication number
PT2726510T
PT2726510T PT127253110T PT12725311T PT2726510T PT 2726510 T PT2726510 T PT 2726510T PT 127253110 T PT127253110 T PT 127253110T PT 12725311 T PT12725311 T PT 12725311T PT 2726510 T PT2726510 T PT 2726510T
Authority
PT
Portugal
Prior art keywords
dual targeting
targeting
dual
Prior art date
Application number
PT127253110T
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT2726510T publication Critical patent/PT2726510T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46Hybrid immunoglobulins
    • C07K16/468Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243Colony Stimulating Factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • C07K16/248IL-6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1058Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
PT127253110T 2011-05-27 2012-05-29 Direcionamento duplo PT2726510T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11004373 2011-05-27

Publications (1)

Publication Number Publication Date
PT2726510T true PT2726510T (pt) 2023-05-03

Family

ID=46207961

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127253110T PT2726510T (pt) 2011-05-27 2012-05-29 Direcionamento duplo

Country Status (19)

Country Link
US (4) US20140206846A1 (pt)
EP (1) EP2726510B1 (pt)
JP (2) JP2014516542A (pt)
CN (2) CN112661848A (pt)
AU (1) AU2012265156B2 (pt)
CA (1) CA2853383C (pt)
DK (1) DK2726510T3 (pt)
ES (1) ES2943577T3 (pt)
FI (1) FI2726510T3 (pt)
HR (1) HRP20230411T1 (pt)
HU (1) HUE061692T2 (pt)
IL (1) IL229649B (pt)
LT (1) LT2726510T (pt)
PL (1) PL2726510T3 (pt)
PT (1) PT2726510T (pt)
RS (1) RS64179B1 (pt)
SG (2) SG10201604279TA (pt)
SI (1) SI2726510T1 (pt)
WO (1) WO2012163520A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2891566A1 (en) 2012-12-05 2014-06-12 Dutalys Gmbh Dual targeting
CN105849124B (zh) * 2013-12-20 2022-04-12 豪夫迈·罗氏有限公司 双重特异性抗体
SG11201609707WA (en) 2014-07-01 2017-01-27 Pfizer Bispecific heterodimeric diabodies and uses thereof
CN107108721B (zh) 2014-09-29 2021-09-07 杜克大学 包含hiv-1包膜靶向臂的双特异性分子
CA2979708A1 (en) 2015-03-19 2016-09-22 Duke University Hiv-1 neutralizing antibodies and uses thereof
WO2016149695A1 (en) 2015-03-19 2016-09-22 Duke University HIV-1 NEUTRALIZING ANTIBODIES AND USES THEREOF (CD4bs ANTIBODIES)
WO2016149698A2 (en) 2015-03-19 2016-09-22 Duke University Hiv-1 neutralizing antibodies and uses thereof (v3 antibodies)
WO2016149710A2 (en) 2015-03-19 2016-09-22 Duke University Hiv-1 neutralizing antibodies and uses thereof
WO2018060035A1 (en) 2016-09-30 2018-04-05 F. Hoffmann-La Roche Ag Spr-based dual-binding assay for the functional analysis of multispecific molecules
EP3330289A1 (en) 2016-12-02 2018-06-06 Friedrich-Alexander-Universität Erlangen-Nürnberg A cd33-, cd16- and cd123-specific single chain triplebody
GB201711208D0 (en) 2017-07-12 2017-08-23 Iontas Ltd Ion channel inhibitors
US20190270806A1 (en) * 2018-03-02 2019-09-05 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
AU2019406712A1 (en) 2018-12-21 2021-06-17 F. Hoffmann-La Roche Ag Antibody that binds to VEGF and IL-1beta and methods of use
EP3903102B1 (en) 2018-12-30 2023-04-12 F. Hoffmann-La Roche AG Ph-gradient spr-based binding assay
WO2020200944A1 (en) 2019-03-29 2020-10-08 F. Hoffmann-La Roche Ag Method for generating avid-binding multispecific antibodies
WO2020200941A1 (en) 2019-03-29 2020-10-08 F. Hoffmann-La Roche Ag Spr-based binding assay for the functional analysis of multivalent molecules
MX2021015540A (es) 2019-06-19 2022-02-10 Hoffmann La Roche Metodo para la generacion de una celula que expresa un anticuerpo trivalente mediante la integracion dirigida de multiples casetes de expresion en una organizacion definida.
JP2022537338A (ja) 2019-06-19 2022-08-25 エフ.ホフマン-ラ ロシュ アーゲー 所定の構成の複数の発現カセットの標的指向性組込みによって二価二重特異性抗体発現細胞を作製するための方法
EP3986924A1 (en) 2019-06-19 2022-04-27 F. Hoffmann-La Roche AG Method for the generation of a multivalent, multispecific antibody expressing cell by targeted integration of multiple expression cassettes in a defined organization
MX2021015536A (es) 2019-06-19 2022-02-10 Hoffmann La Roche Metodo para la generacion de una celula que expresa proteina mediante integracion dirigida usando acido ribonucleico mensajero (arnm) de cre.
MX2021015537A (es) 2019-06-19 2022-02-10 Hoffmann La Roche Metodo para la generacion de una celula que expresa anticuerpo biespecifico multivalente mediante la integracion diana de casetes de expresion multiples en una organizacion definida.
KR20220016957A (ko) 2019-06-26 2022-02-10 에프. 호프만-라 로슈 아게 Sirt-1 유전자 녹아웃을 갖는 포유류 세포주
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
WO2021084104A1 (en) 2019-10-30 2021-05-06 Bioinvent International Ab Tetravalent antibody molecules
JP2023509435A (ja) 2020-01-02 2023-03-08 エフ. ホフマン-ラ ロシュ アーゲー Ada応答特定アッセイ
CN115397850A (zh) 2020-03-30 2022-11-25 豪夫迈·罗氏有限公司 与vegf和pdgf-b结合的抗体及其使用方法
KR20230061458A (ko) 2020-09-04 2023-05-08 에프. 호프만-라 로슈 아게 Vegf-a 및 ang2에 결합하는 항체 및 사용 방법
AU2021347580A1 (en) 2020-09-24 2023-04-06 F. Hoffmann-La Roche Ag Mammalian cell lines with gene knockout
EP4267734A1 (en) 2020-12-22 2023-11-01 F. Hoffmann-La Roche AG Oligonucleotides targeting xbp1
WO2022175217A1 (en) 2021-02-18 2022-08-25 F. Hoffmann-La Roche Ag Method for resolving complex, multistep antibody interactions
EP4320444A1 (en) 2021-04-09 2024-02-14 F. Hoffmann-La Roche AG Process for selecting cell clones expressing a heterologous polypeptide
WO2023117325A1 (en) 2021-12-21 2023-06-29 F. Hoffmann-La Roche Ag Method for the determination of hydrolytic activity
WO2023202967A1 (en) 2022-04-19 2023-10-26 F. Hoffmann-La Roche Ag Improved production cells
WO2023217933A1 (en) 2022-05-11 2023-11-16 F. Hoffmann-La Roche Ag Antibody that binds to vegf-a and il6 and methods of use
WO2023232961A1 (en) 2022-06-03 2023-12-07 F. Hoffmann-La Roche Ag Improved production cells
WO2024079069A1 (en) 2022-10-12 2024-04-18 F. Hoffmann-La Roche Ag Method for classifying cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
US7883704B2 (en) * 1999-03-25 2011-02-08 Abbott Gmbh & Co. Kg Methods for inhibiting the activity of the P40 subunit of human IL-12
DE60137421D1 (de) 2000-06-29 2009-03-05 Abbott Lab Antikörper mit zwei spezifizitäten und verfahren zur deren herstellung und verwendung
DE60237282D1 (de) * 2001-06-28 2010-09-23 Domantis Ltd Doppelspezifischer ligand und dessen verwendung
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
US7749724B2 (en) 2005-07-05 2010-07-06 Washington State University Fluorogenic selective and differential medium for isolation of Enterobacter sakazakii
WO2007112940A2 (en) 2006-03-31 2007-10-11 Ablynx N.V. Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same
EP2471816A1 (en) * 2006-08-30 2012-07-04 Genentech, Inc. Multispecific antibodies

Also Published As

Publication number Publication date
PL2726510T3 (pl) 2023-05-29
AU2012265156B2 (en) 2017-01-19
FI2726510T3 (fi) 2023-05-04
IL229649A0 (en) 2014-01-30
JP6659626B2 (ja) 2020-03-04
HUE061692T2 (hu) 2023-08-28
CN112661848A (zh) 2021-04-16
JP2017221200A (ja) 2017-12-21
US20180094078A1 (en) 2018-04-05
CA2853383C (en) 2021-04-06
SG195196A1 (en) 2013-12-30
CN103930445A (zh) 2014-07-16
WO2012163520A1 (en) 2012-12-06
SG10201604279TA (en) 2016-07-28
US20230279155A1 (en) 2023-09-07
NZ619409A (en) 2016-05-27
WO2012163520A4 (en) 2013-01-24
AU2012265156A1 (en) 2014-01-16
EP2726510B1 (en) 2023-03-08
US20140206846A1 (en) 2014-07-24
RS64179B1 (sr) 2023-05-31
DK2726510T3 (da) 2023-05-15
CN103930445B (zh) 2021-03-09
SI2726510T1 (sl) 2023-06-30
ES2943577T3 (es) 2023-06-14
HRP20230411T1 (hr) 2023-07-07
US20210079119A1 (en) 2021-03-18
CA2853383A1 (en) 2012-12-06
EP2726510A1 (en) 2014-05-07
IL229649B (en) 2019-08-29
LT2726510T (lt) 2023-05-10
JP2014516542A (ja) 2014-07-17

Similar Documents

Publication Publication Date Title
IL229649A0 (en) Dual direction
IL236563A0 (en) Direct search-driven contact
DK3424953T3 (en) Terapeutiske antistoffer
PL2771471T3 (pl) Konstrukt
EP2723631A4 (en) QUADFOILER
AP2014007621A0 (en) 2-Thiopyrimidinones
EP2695208A4 (en) MICRO-THERMOCOUPLE
ZA201304139B (en) Combination
PL2606715T3 (pl) Kombinacja prasująco-owijająca
EP2679138A4 (en) Borescope
EP2708561A4 (en) BIO-PIN
DK2770906T3 (en) Applanationstonometer
EP2684382A4 (en) EARPHONES
EP2698098A4 (en) campimeter
EP2694655A4 (en) pavec
HK1211953A1 (en) Dual targeting
EP2702929A4 (en) campimeter
EP2672969A4 (en) ASSOCIATION
AU4540P (en) BUNNAN Baloskion tetraphyllum
AU5171P (en) Sunparamiho Mandevilla xamabilis
AU5031P (en) BESYS Beschorneria yuccoides
AU5026P (en) Goldstrike Agapanthus inapertus
IL213949A0 (en) Aerial targeting
AP00723S1 (en) Autorickshaw
GB201121105D0 (en) Combination